4th International AIDS Society Conference on HIV Pathogenesis and Treatment


Sydney, Australia - July 22 - 25, 2007

UNDERSTANDING THE TASK: ARV ROLLOUT AND RESEARCH ISSUES IN THE DEVELOPING WORLD

IAS Conf HIV Pathog Treat 2007 Jul 22-25;4th: Abstract No. MOPL101

Dr. Debrework Zewdie
Global HIV/AIDS Program Director, Global Fund to Fight AIDS

Dr. Debrework Zewdie

In her role as Global HIV/AIDS Program Director, Dr. Debrework Zewdie is the Bank’s UNAIDS Global Coordinator and representative on the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Prior to this position she managed the AIDS Campaign Team for Africa, and led the team responsible for the US$1 billion Multi-Country HIV/AIDS Program for Africa.

Before joining the Bank in 1994, Dr. Zewdie was Africa’s Deputy Regional Director for Family Health International’s AIDS Control and Prevention project in Kenya. Previously, Dr. Zewdie held several research, management, and teaching positions focusing on public health issues. While in Ethiopia, she was Deputy Director then Acting Director of the National Research Institute of Health. Dr. Zewdie also established and headed the Referral Laboratory for HIV/AIDS in Ethiopia, served as Program Manager of Ethiopia's AIDS/STD Prevention and Control Program, and taught immunology at Addis Ababa University

She received her Ph.D. in Immunology from the University of London and was a Senior MacArthur Fellow at Harvard University's School of Population and Development Studies. Dr. Zewdie has been published in over 100 journals and book chapters on a variety of subjects.

Acrobat ReaderDownload PDF of this abstract.

Power Point PresentationDownload Power Point Presentation.

2007-07-22
MOPL101
Plenary

Copyright © 2007 - International AIDS Society (IAS). All information and content relating to the abstracts from the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.